PAVM
PAVmed Inc.
Price Chart
Latest Quote
$4.91
-0.25 (-4.84%)
Current Price
| Previous Close | $5.16 |
| Open | $5.26 |
| Day High | $5.68 |
| Day Low | $4.76 |
| Volume | 14,915 |
Stock Information
| Shares Outstanding | 7.16M |
| Total Debt | $17.01M |
| Cash Equivalents | $6.84M |
| Revenue | $85K |
| Net Income | $-28.46M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $35.15M |
| EPS (TTM) | $-48.31 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $34.54M |
| Sales | $85K |
| Income | $-28.46M |
| Book/sh | $10.01 |
| Cash/sh | $0.96 |
| Employees | 41 |
Financial Ratios
| Quick Ratio | 1.87 |
| Current Ratio | 2.02 |
| Debt/Eq | 68.07 |
Returns & Margins
| ROA | -31.04% |
| ROE | -67.22% |
| Gross Margin | -228.24% |
| Operating Margin | -36522.73% |
Ownership
| Insider Ownership | 43.37% |
| Institutional Ownership | 23.50% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.00 |
| P/S | 413.54 |
| P/B | 0.49 |
Analyst Data
| Recommendation | none |
| Target Price | $36.00 |
Technical Indicators
| SMA20 | $5.49 |
| SMA50 | $6.99 |
| SMA200 | $9.80 |
| RSI | 27.21 |
| ATR | 0.5454 |
| Shares Float | 5.21M |
| Short Float | 0.16% |
| Short Ratio | 0.63 |
| Volatility | 0.56 |
| Rel Volume | 0.62 |
Performance History
| Week | -1.80% |
| Month | -19.51% |
| Quarter | -50.20% |
| 6 Months | -45.98% |
| YTD | -33.02% |
| Year | -73.17% |
| 3 Years | -97.22% |
| 5 Years | -99.81% |
| 10 Years | -99.78% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $4.91 | 14,915 |
| 2026-06-18 | $5.16 | 208,300 |
| 2026-06-17 | $5.00 | 4,600 |
| 2026-06-16 | $4.99 | 12,300 |
| 2026-06-15 | $4.83 | 7,800 |
| 2026-06-12 | $5.00 | 17,100 |
| 2026-06-11 | $4.89 | 27,500 |
| 2026-06-10 | $4.98 | 18,600 |
| 2026-06-09 | $4.68 | 37,600 |
| 2026-06-08 | $5.18 | 50,000 |
| 2026-06-05 | $5.45 | 5,400 |
| 2026-06-04 | $5.45 | 10,200 |
| 2026-06-03 | $5.84 | 4,700 |
| 2026-06-02 | $6.00 | 14,000 |
| 2026-06-01 | $6.15 | 4,600 |
| 2026-05-29 | $6.20 | 10,900 |
| 2026-05-28 | $6.27 | 7,200 |
| 2026-05-27 | $6.30 | 3,300 |
| 2026-05-26 | $6.14 | 13,100 |
About PAVmed Inc.
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
đ° Latest News
How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target
Simply Wall St. âĸ 2026-06-01T08:12:47Z
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...
GuruFocus.com âĸ 2026-05-15T23:01:54ZPAVmed (PAVM) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-05-15T15:36:20Z
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-15T13:15:02Z
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-14T13:20:14Z
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-13T22:40:01Z
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-12T21:40:05Z
Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know
Zacks âĸ 2026-05-08T14:00:03Z
Alphatec (ATEC) Reports Break-Even Earnings for Q1
Zacks âĸ 2026-05-05T22:05:05Z
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-04-29T21:45:08Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $113,000 | $4,201,000 | $5,509,000 | $2,941,000 |
| Cost Of Revenue | $218,000 | $4,840,000 | $6,420,000 | $3,614,000 |
| Total Revenue | $71,000 | $2,995,000 | $2,452,000 | $377,000 |
| Operating Revenue | $71,000 | $2,995,000 | $2,452,000 | $377,000 |
| Expenses | ||||
| Interest Expense | $21,000 | $45,000 | $589,000 | $1,281,000 |
| Total Expenses | $21,461,000 | $47,373,000 | $71,247,000 | $91,464,000 |
| Other Income Expense | $18,913,000 | $72,596,000 | $-10,384,000 | $-11,039,000 |
| Other Non Operating Income Expenses | $10,488,000 | $4,312,000 | $-7,212,000 | $-5,605,000 |
| Net Non Operating Interest Income Expense | $8,000 | $209,000 | $-84,000 | $-1,112,000 |
| Interest Expense Non Operating | $21,000 | $45,000 | $589,000 | $1,281,000 |
| Operating Expense | $21,243,000 | $42,533,000 | $64,827,000 | $87,850,000 |
| Other Operating Expenses | $-416,000 | $-109,000 | - | - |
| Selling And Marketing Expense | $917,000 | $11,627,000 | $17,583,000 | $19,318,000 |
| General And Administrative Expense | $16,250,000 | $24,524,000 | $30,947,000 | $41,410,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $401,000 | $39,791,000 | $-64,175,000 | $-88,983,000 |
| Net Interest Income | $8,000 | $209,000 | $-84,000 | $-1,112,000 |
| Interest Income | $29,000 | $254,000 | $505,000 | $169,000 |
| Normalized Income | $459,000 | $-27,961,000 | $-61,003,000 | $-83,549,000 |
| Net Income From Continuing And Discontinued Operation | $401,000 | $39,791,000 | $-64,175,000 | $-88,983,000 |
| Total Operating Income As Reported | $-21,806,000 | $-44,487,000 | $-68,795,000 | $-91,087,000 |
| Average Dilution Earnings | $0 | $428,000 | - | - |
| Net Income Common Stockholders | $-3,774,000 | $31,966,000 | $-66,270,000 | $-89,264,000 |
| Net Income | $401,000 | $39,791,000 | $-64,175,000 | $-88,983,000 |
| Net Income Including Noncontrolling Interests | $-2,469,000 | $28,427,000 | $-79,263,000 | $-103,238,000 |
| Net Income Continuous Operations | $-2,469,000 | $28,427,000 | $-79,263,000 | $-103,238,000 |
| Pretax Income | $-2,469,000 | $28,427,000 | $-79,263,000 | $-103,238,000 |
| Special Income Charges | $-58,000 | $67,752,000 | $-2,782,000 | $-5,434,000 |
| Earnings From Equity Interest | $8,483,000 | $532,000 | $0 | - |
| Interest Income Non Operating | $29,000 | $254,000 | $505,000 | $169,000 |
| Operating Income | $-21,390,000 | $-44,378,000 | $-68,795,000 | $-91,087,000 |
| Depreciation Amortization Depletion Income Statement | $0 | $559,000 | $2,021,000 | $1,784,000 |
| Depreciation And Amortization In Income Statement | $0 | $559,000 | $2,021,000 | $1,784,000 |
| Amortization Of Intangibles Income Statement | $0 | $559,000 | $2,021,000 | $1,784,000 |
| Gross Profit | $-147,000 | $-1,845,000 | $-3,968,000 | $-3,237,000 |
| Per Share | ||||
| Diluted EPS | $1.84 | $15.00 | $-274.80 | $-450.90 |
| Basic EPS | $1.84 | $97.11 | $-274.80 | $-450.90 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,285,000 | $-38,082,000 | $-72,570,000 | $-94,066,000 |
| Total Unusual Items | $-58,000 | $67,752,000 | $-3,172,000 | $-5,434,000 |
| Total Unusual Items Excluding Goodwill | $-58,000 | $67,752,000 | $-3,172,000 | $-5,434,000 |
| Reconciled Depreciation | $105,000 | $1,198,000 | $2,932,000 | $2,457,000 |
| EBITDA (Bullshit earnings) | $-2,343,000 | $29,670,000 | $-75,742,000 | $-99,500,000 |
| EBIT | $-2,448,000 | $28,472,000 | $-78,674,000 | $-101,957,000 |
| Diluted Average Shares | $927,933 | $373,299 | $241,051 | $197,946 |
| Basic Average Shares | $927,933 | $373,299 | $241,051 | $197,946 |
| Diluted NI Availto Com Stockholders | $-3,774,000 | $32,394,000 | $-66,270,000 | $-89,264,000 |
| Preferred Stock Dividends | $4,175,000 | $7,825,000 | $304,000 | $281,000 |
| Minority Interests | $2,870,000 | $11,364,000 | $15,088,000 | $14,255,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Business | $0 | $72,287,000 | $0 | - |
| Other Special Charges | $58,000 | $4,535,000 | $3,782,000 | $5,434,000 |
| Amortization | $0 | $559,000 | $2,021,000 | $1,784,000 |
| Research And Development | $4,492,000 | $5,932,000 | $14,276,000 | $25,338,000 |
| Selling General And Administration | $17,167,000 | $36,151,000 | $48,530,000 | $60,728,000 |
| Other Gand A | $16,250,000 | $24,524,000 | $30,947,000 | $41,410,000 |
| Otherunder Preferred Stock Dividend | - | $0 | $1,791,000 | $0 |
| Gain On Sale Of Ppe | - | $0 | $1,000,000 | $0 |
| Gain On Sale Of Security | - | $462,000 | $-390,000 | $-1,273,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $33,967,000 | $-2,495,000 | $-55,255,000 | $-13,126,000 |
| Total Assets | $38,812,000 | $30,660,000 | $33,119,000 | $53,980,000 |
| Total Non Current Assets | $36,255,000 | $28,496,000 | $8,621,000 | $10,054,000 |
| Other Non Current Assets | $56,000 | $208,000 | $1,147,000 | $1,121,000 |
| Current Assets | $2,557,000 | $2,164,000 | $24,498,000 | $43,926,000 |
| Prepaid Assets | $765,000 | $695,000 | $4,259,000 | $3,904,000 |
| Inventory | $239,000 | $266,000 | $539,000 | $261,000 |
| Receivables | $15,000 | $18,000 | $61,000 | $17,000 |
| Accounts Receivable | $15,000 | $18,000 | $61,000 | $17,000 |
| Cash Cash Equivalents And Short Term Investments | $1,538,000 | $1,185,000 | $19,639,000 | $39,744,000 |
| Cash And Cash Equivalents | $1,538,000 | $1,185,000 | $19,639,000 | $39,744,000 |
| Cash Financial | $1,538,000 | $1,185,000 | $19,639,000 | $39,744,000 |
| Goodwill And Other Intangible Assets | - | $0 | $1,424,000 | $3,445,000 |
| Other Intangible Assets | - | - | $1,424,000 | $3,445,000 |
| Other Current Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $9,562,000 | $27,915,000 | $24,561,000 | - |
| Total Debt | $13,348,000 | $31,860,000 | $48,725,000 | $36,637,000 |
| Long Term Debt And Capital Lease Obligation | $1,675,000 | $2,247,000 | $2,960,000 | $1,846,000 |
| Current Debt And Capital Lease Obligation | $11,673,000 | $29,613,000 | $45,765,000 | $34,791,000 |
| Current Debt | $11,100,000 | $29,100,000 | $44,200,000 | $33,650,000 |
| Other Current Borrowings | $11,100,000 | $29,100,000 | $44,200,000 | $33,650,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $16,512,000 | $37,693,000 | $57,137,000 | $43,046,000 |
| Total Non Current Liabilities Net Minority Interest | $1,675,000 | $2,247,000 | $2,960,000 | $1,846,000 |
| Current Liabilities | $14,837,000 | $35,446,000 | $54,177,000 | $41,200,000 |
| Other Current Liabilities | $769,000 | $362,000 | $777,000 | - |
| Payables And Accrued Expenses | $1,196,000 | $4,320,000 | $5,128,000 | $4,469,000 |
| Payables | $678,000 | $657,000 | $1,786,000 | $2,704,000 |
| Accounts Payable | $678,000 | $657,000 | $1,786,000 | $2,704,000 |
| Current Notes Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $9,289,000 | $-5,811,000 | $-56,824,000 | $-12,376,000 |
| Preferred Stock Equity | $24,678,000 | $3,316,000 | $2,993,000 | $2,695,000 |
| Total Equity Gross Minority Interest | $22,300,000 | $-7,033,000 | $-24,018,000 | $10,934,000 |
| Stockholders Equity | $33,967,000 | $-2,495,000 | $-53,831,000 | $-9,681,000 |
| Retained Earnings | $-258,731,000 | $-254,965,000 | $-294,433,000 | $-228,169,000 |
| Long Term Equity Investment | $34,120,000 | $25,637,000 | $0 | - |
| Other | ||||
| Ordinary Shares Number | $927,933 | $373,299 | $285,950 | $210,023 |
| Share Issued | $927,933 | $373,299 | $285,950 | $210,023 |
| Tangible Book Value | $9,289,000 | $-5,811,000 | $-58,248,000 | $-15,821,000 |
| Invested Capital | $20,389,000 | $23,289,000 | $-12,624,000 | $21,274,000 |
| Working Capital | $-12,280,000 | $-33,282,000 | $-29,679,000 | $2,726,000 |
| Capital Lease Obligations | $2,248,000 | $2,760,000 | $4,525,000 | $2,987,000 |
| Total Capitalization | $33,967,000 | $-2,495,000 | $-53,831,000 | $-9,681,000 |
| Minority Interest | $-11,667,000 | $-4,538,000 | $29,813,000 | $20,615,000 |
| Additional Paid In Capital | $268,019,000 | $249,153,000 | $237,600,000 | $216,195,000 |
| Capital Stock | $24,679,000 | $3,317,000 | $3,002,000 | $2,701,000 |
| Common Stock | $1,000 | $1,000 | $9,000 | $6,000 |
| Preferred Stock | $24,678,000 | $3,316,000 | $2,993,000 | $2,695,000 |
| Long Term Capital Lease Obligation | $1,675,000 | $2,247,000 | $2,960,000 | $1,846,000 |
| Current Capital Lease Obligation | $573,000 | $513,000 | $1,565,000 | $1,141,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,199,000 | $1,151,000 | $2,507,000 | $1,940,000 |
| Current Accrued Expenses | $518,000 | $3,663,000 | $3,342,000 | $1,765,000 |
| Investments And Advances | $34,120,000 | $25,637,000 | $0 | - |
| Net PPE | $2,079,000 | $2,651,000 | $6,050,000 | $5,488,000 |
| Accumulated Depreciation | $-1,358,000 | $-1,253,000 | $-1,719,000 | $-808,000 |
| Gross PPE | $3,437,000 | $3,904,000 | $7,769,000 | $6,296,000 |
| Leases | $1,000 | $1,000 | $2,000 | $2,000 |
| Construction In Progress | $2,000 | $2,000 | $16,000 | $30,000 |
| Other Properties | $2,555,000 | $3,053,000 | $6,522,000 | $5,101,000 |
| Machinery Furniture Equipment | $879,000 | $848,000 | $1,229,000 | $1,163,000 |
| Properties | $0 | $0 | $0 | $0 |
| Raw Materials | $239,000 | $266,000 | $261,000 | $150,000 |
| Treasury Stock | - | - | $0 | $408,000 |
| Other Inventories | - | - | $278,000 | $111,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,237,000 | $-33,609,000 | $-52,278,000 | $-72,525,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,206,000 | $-33,554,000 | $-52,036,000 | $-70,985,000 |
| Cash Flow From Continuing Operating Activities | $-5,206,000 | $-33,554,000 | $-52,036,000 | $-70,985,000 |
| Operating Gains Losses | $-8,425,000 | $-70,284,000 | $2,782,000 | $5,434,000 |
| Investing Activities | ||||
| Capital Expenditure | $-31,000 | $-55,000 | $-242,000 | $-1,540,000 |
| Investing Cash Flow | $-31,000 | $-16,184,000 | $758,000 | $-4,740,000 |
| Cash Flow From Continuing Investing Activities | $-31,000 | $-16,184,000 | $758,000 | $-4,740,000 |
| Net Other Investing Changes | - | - | - | $-3,200,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $5,699,000 | $31,396,000 | $20,442,000 | $1,886,000 |
| Financing Cash Flow | $5,590,000 | $31,284,000 | $31,173,000 | $38,211,000 |
| Cash Flow From Continuing Financing Activities | $5,590,000 | $31,284,000 | $31,173,000 | $38,211,000 |
| Net Other Financing Charges | $-109,000 | - | - | - |
| Net Preferred Stock Issuance | $0 | $29,798,000 | $18,625,000 | $0 |
| Preferred Stock Issuance | $0 | $29,798,000 | $18,625,000 | $0 |
| Net Common Stock Issuance | $5,699,000 | $1,598,000 | $1,817,000 | $1,520,000 |
| Common Stock Issuance | $5,699,000 | $1,598,000 | $1,817,000 | $1,886,000 |
| Repurchase Of Capital Stock | - | - | $0 | $-366,000 |
| Other | ||||
| Repayment Of Debt | $0 | $-531,000 | $-79,000 | $0 |
| End Cash Position | $1,538,000 | $1,185,000 | $19,639,000 | $39,744,000 |
| Beginning Cash Position | $1,185,000 | $19,639,000 | $39,744,000 | $77,258,000 |
| Changes In Cash | $353,000 | $-18,454,000 | $-20,105,000 | $-37,514,000 |
| Proceeds From Stock Option Exercised | $0 | $419,000 | $810,000 | $1,464,000 |
| Net Issuance Payments Of Debt | $0 | $-531,000 | $9,921,000 | $35,227,000 |
| Net Short Term Debt Issuance | $0 | $-531,000 | $9,921,000 | $35,227,000 |
| Short Term Debt Payments | $0 | $-531,000 | $-79,000 | $0 |
| Net Business Purchase And Sale | $0 | $-16,479,000 | $0 | $-3,200,000 |
| Purchase Of Business | $0 | $-16,479,000 | $0 | $-3,200,000 |
| Net Intangibles Purchase And Sale | $0 | $350,000 | $1,000,000 | $0 |
| Sale Of Intangibles | $0 | $350,000 | $1,000,000 | $0 |
| Net PPE Purchase And Sale | $-31,000 | $-55,000 | $-242,000 | $-1,540,000 |
| Purchase Of PPE | $-31,000 | $-55,000 | $-242,000 | $-1,540,000 |
| Change In Working Capital | $98,000 | $512,000 | $1,591,000 | $-716,000 |
| Change In Payables And Accrued Expense | $-14,000 | $-363,000 | $1,881,000 | $-1,296,000 |
| Change In Accrued Expense | $-38,000 | $-304,000 | $2,799,000 | $-554,000 |
| Change In Payable | $24,000 | $-59,000 | $-918,000 | $-742,000 |
| Change In Account Payable | $24,000 | $-59,000 | $-918,000 | $-742,000 |
| Change In Prepaid Assets | $109,000 | $832,000 | $-246,000 | $397,000 |
| Change In Receivables | $3,000 | $43,000 | $-44,000 | $183,000 |
| Changes In Account Receivables | $3,000 | $43,000 | $-44,000 | $183,000 |
| Other Non Cash Items | $3,778,000 | $144,000 | $8,783,000 | $5,546,000 |
| Stock Based Compensation | $1,707,000 | $6,449,000 | $11,139,000 | $19,532,000 |
| Depreciation Amortization Depletion | $105,000 | $1,198,000 | $2,932,000 | $2,457,000 |
| Depreciation And Amortization | $105,000 | $1,198,000 | $2,932,000 | $2,457,000 |
| Amortization Cash Flow | $0 | $559,000 | $2,021,000 | - |
| Amortization Of Intangibles | $0 | $559,000 | $2,021,000 | - |
| Depreciation | $105,000 | $639,000 | $911,000 | - |
| Earnings Losses From Equity Investments | $-8,483,000 | $-532,000 | $0 | - |
| Gain Loss On Sale Of Business | $0 | $-72,287,000 | $0 | - |
| Net Income From Continuing Operations | $-2,469,000 | $28,427,000 | $-79,263,000 | $-103,238,000 |
| Issuance Of Debt | - | $0 | $10,000,000 | $35,227,000 |
| Short Term Debt Issuance | - | $0 | $10,000,000 | $35,227,000 |
| Gain Loss On Sale Of PPE | - | $0 | $-1,000,000 | $0 |
| Common Stock Payments | - | - | $0 | $-366,000 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-18